Covered recipient · General Payments record
AJIBOLA RAJI
General Payments · PY2024–2025
$445.23
- Reported across 17 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $425.06 | 16 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $139.27 | 6 |
| Medtronic, Inc. | $95.78 | 2 |
| Corcept Therapeutics | $56.18 | 2 |
| Novo Nordisk AS | $42.96 | 2 |
| Organon LLC | $28.82 | 1 |
| Exact Sciences Corporation | $24.55 | 1 |
| Astellas Pharma US Inc | $18.93 | 1 |
| Phadia US Inc. | $18.57 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (16)
Sorted by paying entity, then date · as published by CMS
Program year 2025 2024
Record-level detail is published for PY2025; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $18.93 | 04/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238630203 | CMS |
| Corcept Therapeutics | $28.62 | 08/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214164484 | CMS |
| Corcept Therapeutics | $27.56 | 09/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214164585 | CMS |
| Exact Sciences Corporation | $24.55 | 04/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235408027 | CMS |
| Lilly USA, LLC | $19.59 | 03/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186946205 | CMS |
| Lilly USA, LLC | $23.07 | 05/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186974564 | CMS |
| Lilly USA, LLC | $21.99 | 05/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186980648 | CMS |
| Lilly USA, LLC | $25.12 | 07/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186980650 | CMS |
| Lilly USA, LLC | $21.02 | 09/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186989536 | CMS |
| Lilly USA, LLC | $28.48 | 10/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187049695 | CMS |
| Medtronic, Inc. | $41.67 | 11/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1220047685 | CMS |
| Medtronic, Inc. | $54.11 | 12/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1220047683 | CMS |
| Novo Nordisk Inc | $20.49 | 03/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188633478 | CMS |
| Novo Nordisk Inc | $22.47 | 10/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188928084 | CMS |
| Organon LLC | $28.82 | 08/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1237715264 | CMS |
| Phadia US Inc. | $18.57 | 05/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1161492596 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2024, 2025
- Source files
- Dataset page · Bulk file · PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.